Background. Prediction of mortality may improve management and outcomes of patients with sepsis in resource-limited settings. Therefore, we evaluated the ability of a hand-held portable whole-blood lactate (PWBL) analyzer to predict mortality of patients who are admitted to the hospital with severe sepsis.
United States [3] [4] [5] [6] . Similarly, sepsis due to bacteremia is an increasingly recognized cause of death in subSaharan Africa [7, 8] . HIV-1 infection and malnutrition, both common in sub-Saharan Africa, are independently associated with bacteremia [7] .
Infection may cause a systemic inflammatory response syndrome, which can lead to death through a series of clinical transitions from sepsis to severe sepsis to septic shock, for which the mortality rate is 15%-45% [9] . During this progression, worsening cardiovascular compromise can lead to global tissue hypoxia, organ failure, and, ultimately, death. As tissue perfusion decreases, lactate concentrations increase because of anaerobic cellular respiration. Elevated blood lactate concentration and failure to clear lactatemia during the first 6 h after presentation are associated with mortality in patients with severe sepsis [10] [11] [12] . Lactate concentration-along with mixed venous oxygen saturation, base deficit, and pH-is used to guide early goaldirected therapy of sepsis [13] . Early goal-directed therapy employs fluid resuscitation, vasopressors, and blood transfusion to maximize oxygen delivery to distal tissues. A study of early goal-directed therapy reduced in-hospital mortality of patients admitted with sepsis by 16%, from 46.5% to 30.5%, but this therapeutic strategy relies on expensive laboratory assays [13] . Unfortunately, these technologies are not available in most of sub-Saharan Africa. This resource constraint may lead to increased mortality of patients with sepsis. Therefore, the primary goal of this study was to determine whether a hand-held portable whole-blood lactate (PWBL) analyzer could predict mortality of patients with severe sepsis; the secondary goal was to compare results of PWBL analysis with those of available standard laboratory serum lactate (SLSL) analysis in a resourcelimited setting.
METHODS

Patient recruitment.
We enrolled 253 patients to study the incidence, management, and outcomes of patients with severe sepsis in a resource-limited setting; within this group, the PWBL concentration was measured consecutively in the first and last 50 patients enrolled. Complete data were available for 72 patients. Consent was obtained from each patient or his or her guardian.
Patients were recruited from the accident and emergency department of Mulago Hospital, a national referral hospital in Kampala, Uganda. Inclusion criteria were age у18 years and admission to a medical ward, along with (1) у2 systemic inflammatory response syndrome criteria (body temperature, Data collection. Background information-including age, sex, HIV-1 serostatus, and prescribed antiretroviral medicines (ARVs)-was recorded. At enrollment, temperature, heart rate, respiratory rate, and blood pressure were measured. The study team observed patients throughout their hospitalizations, but the admitting medical team was responsible for clinical management. To determine outpatient survival, an attempt was made to telephone patients 30 days after their discharge from the hospital.
Laboratory evaluation. A rapid HIV-1 test and malaria smear were performed at Mulago Hospital. A local private clinical laboratory provided results of lactate and bicarbonate analysis. PWBL was obtained by using a lancet to collect a drop of whole blood from the patient's finger, for analysis by a handheld portable device (Accutrend Portable Lactate Analyzer; Sports Resource Group). This instrument uses enzymatic determination and reflectance photometry of lactate in the plasma portion of whole blood by use of a measurement strip. Results are available within 60 s of blood application. SLSL concentration was obtained by phlebotomy for venous blood samples. Because of hypotension in this study population, a tourniquet was required. Within 2 h of sample collection, the sample was transported in a standard serum tube via a cooler to the clinical laboratory, where blood was centrifuged and serum was removed for use in the lactate assay (Diagnostic Systems International).
Because of discrepancies between PWBL and SLSL, clinical laboratory procedures were reviewed. A subset of patients also had a portable serum lactate (PSL) evaluation by an additional hand-held portable lactate analyzer at the time of evaluation of SLSL. At all times, the clinical laboratory personnel were blind to PWBL results. Once values were known, all laboratory results were provided to the patients' medical team.
Statistical analysis. Data were entered into an EpiInfo database (Centers for Disease Control and Prevention) and were analyzed using SPSS software (SPSS). Descriptive statistics were reported as mean ‫ע‬ SD for all continuous variables, and frequency was reported for all categorical variables. The Student's paired sample t test and Levine's test for equality of variance were used to compare mean differences between patient test results. The Wilcoxon signed rank test was applied when distribution assumptions were not met for Student's paired t test. Statistical significance was defined as . Results of differ-P ! .05 ent lactate tools were compared by plotted mean differences, with limits of agreement (defined as mean SD) difference ‫ע‬ 2 with averaged test score, as recommended by Bland and Altman [14] . Pearson correlations and linear regression were used to describe the strength of the linear relationship between variables. The predictive power of lactate tests for the bivariate mortality outcome variables was assessed using multivariate logistic regression. Covariates were included in the multivariate logistic regression model if they met a inclusion criteria. P р .20 The receiver operating characteristic (ROC) area under the curve for lactate concentration assessed overall accuracy in mortality prediction. Cutoff lactate concentrations were set and then used to quantitatively calculate sensitivity and specificity in prediction of mortality. The lactate cutoff with the maximum sum of sensitivity and specificity for predicting mortality was reported as the curve inflexion point. ORs were also reported to compare risk of death associated with lactate categories by test type. 
RESULTS
Patient characteristics and outcomes.
The demographic characteristics and outcomes of the study sample are described in table 1. These 72 patients were similar to the larger study population in age (mean age, 35.7 vs. 33.8 years), sex (61.1% vs. 59.1% female), HIV-1 seropositivity (81.9% vs. 86.6%), and ARV status (13.9% vs. 10.6% ARVs prescribed) (table 2). The overall in-hospital mortality rate was 25.7% (18 of 70); 2 patients were lost to follow-up, compared with 24.5% (61 of 249) for the larger group. Follow-up information was available at 30 days for 44 of 52 discharged patients. From this group, 12 (27.3%) of 44 patients died. Complete information was unavailable for 10 enrolled patients, so the total in-and outpatient mortality at 30 days was, at minimum, 41.6% (30 of 72) versus 37.9% for the larger group. None of these differences were statistically significant. Six (8.3%) of 72 patients had malaria parasitemia, of whom none had high-grade 4+ parasitemia.
Lactate
). An ROC value indicated good P ! .001 utility of PWBL for predicting in-hospital mortality (ROC area under the curve, 0.81; 95% CI, 0.71-0.92;
). P ! .001 Figures 1 and 2 show the frequency and proportion of inhospital death, as measured by PWBL concentration. A PWBL concentration of 2.6 mmol/L provided very high sensitivity (100%) but low specificity (40.4%) for in-hospital mortality. The ROC curve inflexion point showed that a PWBL concentration of 4.0 mmol/L provides optimal sensitivity (88.3%) and specificity (71.2%) for in-hospital mortality (figure 3). Patients with a PWBL concentration у4.0 mmol/L died while hospitalized significantly more often (50.0%) than did those with a PWBL concentration !4.0 mmol/L (7.5%) (OR, 12.3; 95% CI, 3.5-48.9;
). P ! .001 ). P p .004 To directly compare PWBL and SLSL concentrations in predicting in-hospital mortality, we constructed a 2-step multiple logistic regression model. Mortality prediction power of SLSL was equally poor before and after review of laboratory procedures (Nagelkerke pseudo ).
Step 1 of the model 2 R p 0.12 included only SLSL, whereas step 2 included both SLSL and PWBL. In step 1, SLSL concentration was a significant predictor of in-hospital mortality (SLSL у2.0 mmol/L; OR, 5.2; 95% CI, 1.5-17.9;
). In step 2, entry of PWBL concentration P p .012 (14.0 mmol/L; OR, 9.5; 95% CI 2.0-46.7;
) entirely P ! .001 accounted for the predictive utility of SLSL (у2.0 mmol/L, OR, 1.60; 95% CI, 0.34-7.5;
). All predictive value of PWBL P p .65 for 30-day survival was accounted for by in-hospital mortality. The 12 patients who died after hospital discharge were equally likely to have had a high (у2.6 mmol/L) or low (!2.6 mmol/ ). Figure 4 shows a Bland-Altman analysis of P ! .001 mean difference, with limits of agreement plotted against averaged otlevel (average as measured by both methods). Lactate test differences were highly linearly related ( ; 2 R p 0.89 P ! ) to average level of lactate, indicating greater discrepancies .001 at higher lactate concentrations.
Because of these discrepancies, we requested that the laboratory review its procedures and conduct a second set of SLSL tests on 33 more patients. No changes were made in collection or transport of patient blood to the laboratory, and no changes were made in PWBL collection conditions and methods. No specific cause of inaccuracy of SLSL was elucidated. After laboratory review, linear regression of PWBL on SLSL showed closer correspondence of test results ( ; ). ). In addition, we compared SLSL with PSL, P p .007 and we noted a stronger linear relationship ( ; 2 R p 0.97 P ! ). A paired-sample t test showed that PSL results were .001 significantly higher than SLSL results (mean difference, 0.66 mmol/L; limits of agreement, 2 SD ‫ע‬ 1.34 mmol/L; P ! ). .001
DISCUSSION
This study of lactate level as a mortality prediction tool for patients with severe sepsis is unique, because we evaluated a predominantly HIV-1-infected patient population in a resource-limited setting. For the first time, we have shown that a hand-held PWBL analyzer is capable of predicting mortality of patients with severe sepsis or septic shock. The instrument can be used quickly and easily by auxiliary medical personnel, who are often at the forefront of care in regions where trained physicians, nurses, and laboratory personnel are scarce [15] . The same instrument has been used in resource-limited settings to evaluate lactic acidosis precipitated by use of ARVs [16] .
We found that a PWBL concentration of 2.6 mmol/L was the most sensitive (100%) marker for mortality, because no patient with PWBL !2.6 mmol/L at hospital admission died while in the hospital. However, the low specificity of this value (40.4%) for mortality makes it a poor clinical indicator. Our assessment of the optimal cutoff value for PWBL agrees with those of SLSL studies that 4.0 mmol/L offers the best combined sensitivity (88.3%) and specificity (71.2%) for mortality and should be used in the clinical assessment of septic patients [10, 11, 13] . In our study, the finding of a PWBL concentration у4.0 mmol/L meant that the patient had a 7-fold greater chance of dying in the hospital, compared with a value !4.0 mmol/L. Similar to SLSL studies, PWBL outperformed blood pressure assessment and bicarbonate concentration in predicting mortality [13, 17] . We found no significant association between the use of ARVs (including stavudine) and elevated PWBL concentration.
Although PWBL concentration accurately predicted in-hospital mortality, there was no independent association between lactatemia and death at 30 days. This is, perhaps, related to the 82% HIV-1 seropositivity rate of our study population. Not only are HIV-1-infected patients predisposed to bacteremia and, therefore, sepsis, but they are also more likely to contract opportunistic infections and harbor chronic illnesses that cause early mortality. It is also possible that irreparable physiologic harm leads to delayed death, even after recovery from acute sepsis.
Other studies have documented excellent intra-assay precision and strong linear association between PWBL and SLSL [18] [19] [20] . One study found that use of PWBL analysis was the cheapest and fastest option, when compared with a bench-top lactate analyzer and SLSL [20] . In our study, PWBL served as a quality assurance tool by identifying SLSL inconsistency. SLSL results improved after a review of laboratory procedures but still remained lower overall than PWBL results. We avoided bias by having laboratory personnel blind to PWBL results. Because association was highest between PSL and SLSL, we suggest that both whole blood and serum can be effectively evaluated by the hand-held lactate analyzer. Although SLSL was somewhat predictive of mortality, PWBL had a better sensitivity (88.3% vs. 77.7%) and specificity (71.2% vs. 67.3%) for mortality and an improved predictive value when compared with SLSL (81% vs. 72%). Although PWBL was a good predictor of in-hospital mortality within this sample, larger studies should be conducted to verify this finding and to examine its use in determining the extent of fluid resuscitation in resource-limited settings.
The lack of reliable laboratory diagnostic testing in resourcelimited settings often leads to clinical misdiagnosis [2] . A frequently cited example of this phenomenon is the overdiagnosis of malaria in febrile patients, which often occurs to the exclusion of other diagnoses, notably bacteremia [21] [22] [23] . Six (8.3%) of the patients in our study had malaria parasitemia, of whom none had high-grade 4+ parasitemia, which leads us to believe that patients had sepsis due to infections other than malaria.
The reasons for misdiagnoses are multifactorial but include a lack of both human and material resources. Additionally, as with SLSL in our study, diagnostic inaccuracy can still exist, despite the presence of laboratory equipment [24] . Experts have suggested prioritizing provision of basic accurate laboratory testing in resource-limited settings that should (1) be performed on site in rural primary health care settings, (2) require minimal sample preparation or preservation, (3) be kit based, and (4) be able to be performed with little technical expertise [2] . The use of PWBL concentration in the assessment of septic patients meets this 4-pronged approach to laboratory evaluation.
The World Health Organization promotes clinical treatment algorithms through the Integrated Management of Adult and Adolescent Illness guidelines [25] . PWBL testing can quickly identify patients who require immediate interventions and should be included in evaluation and treatment algorithms for septic patients. PWBL testing could be used in village health posts, for earlier transfer of septic patients to facilities with a higher level of care, and in referral hospitals, for triage of patients to acute care settings where appropriate resuscitation can begin. Therefore, we suggest that PWBL testing be made an important priority for the diagnosis and treatment of severely ill patients in resource-limited settings where the lack of laboratory infrastructure and reliability is a barrier to patient care.
